Every few years, the number of people who “need” cholesterol-lowering (statin) drugs is suddenly expanded. At this rate, it won’t be very long before someone suggests that everyone take them, cradle to grave. The companies that make the drugs would certainly approve of that idea.
Although the AAP maintains that these new guidelines have nothing to do with any commercial entities, the New York Times uncovered some pretty glaring connections.
For starters, the AAP has received contributions from several drug makers, including:
* $433,000 from Merck
* $835,250 from Abbott Laboratories’ Ross Product Division
* $216,000 from the Bristol-Myers Squibb company Mead Johnson Nutritionals
Meanwhile, several members of AAP’s nutrition committee, which developed the new guidelines, also have ties to drug makers:
Speaking of drugs, the government - while delcaring war on so-called recreational drugs - promotes prescription drug use (or abuse) as long as the contributions from the pharmaceutical companies keep rolling in.
No comments:
Post a Comment